Literature DB >> 9681337

delta 9-THC metabolites in meconium: identification of 11-OH-delta 9-THC, 8 beta,11-diOH-delta 9-THC, and 11-nor-delta 9-THC-9-COOH as major metabolites of delta 9-THC.

M A ElSohly1, S Feng.   

Abstract

Gas chromatography-mass spectrometry (GC-MS) analysis of meconium specimens screening positive for cannabinoids by the EMIT 20 Assay showed a low confirmation rate for 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH). A study was designed to investigate the possible contribution of other delta 9-tetrahydrocannabinol (THC) metabolites, including glucuronides, to the overall response of the EIA. delta 9-THC-glucuronide was synthesized in order to develop the most efficient procedure for hydrolysis of glucuronides in meconium. Procedures were developed for the extraction and GC-MS analysis of delta 9-THC, 11-OH-delta 9-THC, 8 alpha- and 8 beta-OH-delta 9-THC, 8 beta,11-diOH-delta 9-THC, and THCCOOH, after enzymatic hydrolysis of meconium extracts. It is concluded that enzymatic hydrolysis of meconium extracts is necessary for efficient recovery of delta 9-THC metabolites; delta 9-THC and its 8-OH metabolite(s) are basically absent in meconium specimens; and 11-OH-delta 9-THC and 8 beta,11-diOH-delta 9-THC contribute significantly to the immunoassay response of meconium extracts. Analysis of several meconium specimens that screened positive for cannabinoids but failed to confirm for THCCOOH showed significant amounts of 11-OH-delta 9-THC and 8 beta,11-diOH-delta 9-THC. Therefore, GC-MS confirmation of cannabinoids in meconium should include analysis for these two metabolites in addition to THCCOOH.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681337     DOI: 10.1093/jat/22.4.329

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  10 in total

1.  Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry.

Authors:  David M Schwope; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2011-07-05       Impact factor: 4.142

2.  Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth.

Authors:  Teresa R Gray; Rina D Eiden; Kenneth E Leonard; Gerard J Connors; Shannon Shisler; Marilyn A Huestis
Journal:  Clin Chem       Date:  2010-07-13       Impact factor: 8.327

Review 3.  Bioanalytical procedures for monitoring in utero drug exposure.

Authors:  Teresa Gray; Marilyn Huestis
Journal:  Anal Bioanal Chem       Date:  2007-03-17       Impact factor: 4.142

4.  New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates.

Authors:  Teresa R Gray; Tamsin Kelly; Linda L LaGasse; Lynne M Smith; Chris Derauf; Penny Grant; Rizwan Shah; Amelia Arria; William Haning; Sheri Della Grotta; Arthur Strauss; Barry M Lester; Marilyn A Huestis
Journal:  Clin Chem       Date:  2010-02-25       Impact factor: 8.327

5.  Effect of hydrolysis on identifying prenatal cannabis exposure.

Authors:  Teresa R Gray; Allan J Barnes; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2010-06-02       Impact factor: 4.142

6.  Detection of in utero Exposure to Cannabis in Paired Umbilical Cord Tissue and Meconium by Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Triniti L Jensen; Fang Wu; Gwendolyn A McMillin
Journal:  Clin Mass Spectrom       Date:  2019-01-24

7.  Simultaneous GC-EI-MS determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis.

Authors:  Tsadik T Abraham; Ross H Lowe; Stephane O Pirnay; William D Darwin; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2007-10       Impact factor: 3.367

8.  Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.

Authors:  Eugene W Schwilke; David M Schwope; Erin L Karschner; Ross H Lowe; William D Darwin; Deanna L Kelly; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-10-15       Impact factor: 8.327

9.  Novel biomarkers of prenatal methamphetamine exposure in human meconium.

Authors:  Teresa R Gray; Tamsin Kelly; Linda L LaGasse; Lynne M Smith; Chris Derauf; William Haning; Penny Grant; Rizwan Shah; Amelia Arria; Arthur Strauss; Barry M Lester; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2009-02       Impact factor: 3.681

Review 10.  Pharmacokinetics of Cannabis and Its Derivatives in Animals and Humans During Pregnancy and Breastfeeding.

Authors:  Anaëlle Monfort; Ema Ferreira; Grégoire Leclair; Gregory Anton Lodygensky
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.